Page last updated: 2024-08-21

pyrazines and Colonic Polyps

pyrazines has been researched along with Colonic Polyps in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brenner, DE; Krishnan, K; Ruffin, MT1
Benson, AB; Dolan, ME; French, S; Mobarhan, S; Olopade, OI; Rademaker, A; Ratain, MJ; Stucky-Marshall, L1
Brennan, JM; Gallo, JM; Laub, PB; O'Dwyer, PJ; Szarka, C1

Reviews

1 review(s) available for pyrazines and Colonic Polyps

ArticleYear
Chemoprevention for colorectal cancer.
    Critical reviews in oncology/hematology, 2000, Volume: 33, Issue:3

    Topics: Adenoma; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Antioxidants; Apoptosis; Arachidonic Acids; Bile Acids and Salts; Biomarkers; Calcium; Cell Cycle; Cell Transformation, Neoplastic; Clinical Trials as Topic; Colonic Polyps; Colorectal Neoplasms; DNA Methylation; DNA Repair; Eflornithine; Enzyme Inhibitors; Estrogens; Free Radical Scavengers; Genetic Predisposition to Disease; Humans; Mice; Ornithine Decarboxylase Inhibitors; Patient Compliance; Patient Selection; Polyamines; Precancerous Conditions; Pyrazines; Rats; Retinoids; Thiones; Thiophenes; Tumor Cells, Cultured; Vitamins

2000

Trials

2 trial(s) available for pyrazines and Colonic Polyps

ArticleYear
Chronic daily low dose of 4-methyl-5-(2-pyrazinyl)-1,2-dithiole-3-thione (Oltipraz) in patients with previously resected colon polyps and first degree female relatives of breast cancer patients.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2000, Volume: 6, Issue:10

    Topics: Anticarcinogenic Agents; Biopsy; Breast Neoplasms; Colonic Polyps; Dose-Response Relationship, Drug; Female; Glutathione; Glutathione Transferase; Hot Temperature; Humans; Lymphocytes; Male; Pyrazines; Rectum; Thiones; Thiophenes; Time Factors

2000
Pharmacokinetics of the chemopreventive agent oltipraz and of its metabolite M3 in human subjects after a single oral dose.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2000, Volume: 6, Issue:12

    Topics: Administration, Oral; Anticarcinogenic Agents; Area Under Curve; Calibration; Chromatography, High Pressure Liquid; Colonic Polyps; Colorectal Neoplasms; Dose-Response Relationship, Drug; Female; Humans; Kinetics; Male; Pyrazines; Risk Factors; Thiones; Thiophenes; Time Factors

2000